AZ and Vanderbilt collaborate on allosteric modulators

AstraZeneca Plc has entered a research collaboration with Vanderbilt University of the US to identify allosteric modulators that could be used to treat psychosis and other symptoms of Alzheimer’s disease and schizophrenia.